ADUpdating your news feed...

NEWS EXPRESS is Nigeria’s leading online newspaper. Published by Africa’s international award-winning journalist, Mr. Isaac Umunna, NEWS EXPRESS is Nigeria’s first truly professional online daily newspaper. It is published from Lagos, Nigeria’s economic and media hub, and has a provision for occasional special print editions. Thanks to our vast network of sources and dedicated team of professional journalists and contributors spread across Nigeria and overseas, NEWS EXPRESS has become synonymous with newsbreaks and exclusive stories from around the world.




















Loading banners
Loading banners...


By BONIFACE AKARAH
The National Agency for Food and Drug Administration and Control (NAFDAC) has recorded significant progress in regulatory enforcement, digital innovation, local pharmaceutical manufacturing and international collaboration in 2026, reinforcing Nigeria’s position in Africa’s medicines regulation landscape.
The achievements were highlighted during the Agency’s regulatory update presentation at the International Pharmaceutical Regulators Programme (IPRP) Management Committee Meeting held in Prague, Czech Republic, from November 18 to 19, 2026, where NAFDAC also received commendation.
A major milestone is the Agency’s sustained World Health Organisation (WHO) Maturity Level 3 status and ongoing transition towards Maturity Level 4, the highest level under the WHO Global Benchmarking Tool.
To support this transition, NAFDAC has introduced and strengthened several digital initiatives, including the Integrated Regulatory Information Management System (IRIMS), Performance Management System (i-PMS), GMP Inspection (GMPi), Application and AI-assisted Technical Screening Tools (TST), as well as a revised Med Safety App.
The digital initiatives are expected to strengthen regulatory processes and improve the reporting of substandard and falsified medical products and adverse drug reactions in Nigeria.
NAFDAC also recorded substantial enforcement activities between January and August 2026, carrying out 5,542 enforcement operations, 213 raids, 821 product seizures, 179 premises closures, 52 arrests and 221 sanctions.
Within the period, the Agency conducted 22 destruction exercises during which unwholesome products valued at approximately ?22.73 billion were destroyed as part of efforts to protect public health and safeguard consumers.
In the pharmaceutical manufacturing sector, the Agency recorded progress under its 5+5 Policy, with more than 70 per cent of finished pharmaceutical products covered by the policy and Ceiling 36 products now manufactured locally.
The initiative is aimed at reducing dependence on imported medicines and strengthening Nigeria’s capacity to produce essential pharmaceutical products.
NAFDAC’s growing role in regional regulatory cooperation was also reflected in its emergence as a reference National Regulatory Authority, hosting regulatory authorities from Uganda, The Gambia, Mozambique and Côte d’Ivoire for technical capacity building and institutional benchmarking.
Nigeria further strengthened its participation in continental medicines regulation with the ratification of the African Medicines Agency (AMA) Treaty and the deposit of its instruments of ratification on October 25, 2026.
The milestones were attributed to the strategic leadership of NAFDAC Director-General, Prof. Mojisola Christianah Adeyeye, whose administration has continued to pursue institutional transformation, science-based regulation, digital innovation and international regulatory cooperation.
The Agency said the achievements reflected its commitment to strengthening regulatory capacity, protecting public health and positioning Nigeria as a leading regulatory authority on the African continent.